Pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in?
The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive. (Twenty-three thousand die.) These experiences leave deep impressions not just on the patients but on their family and friends.
Michael Kinch, PhD, associate vice chancellor and director of the Center for Research Innovation in Business, is among that number. A few years ago his 12-year-old son suddenly became ill, so ill Kinch had to carry him into a nearby clinic in his arms. Because his son had a fever, the doctors at the clinic put him on first one and then a second antibiotic while they worked on a diagnosis.
They soon learned his son’s appendix had burst and he was septic. “Things moved so fast he was septic before he was symptomatic [for appendicitis],” Kinch said. His son was moved to an academic medical center where he had surgery and was put on four newer antibiotics.
When the lab tests for antibiotic susceptibility finally came in, they showed the pathogenic bacteria were susceptible to only two of the six antibiotics Kinch’s son had been given. Stunningly, the two that worked were the older drugs he had been given at the clinic. “I can only assume that if we had gone straight to the academic medical center, he might not have survived,” Kinch said.
“It’s not that my son had had extensive exposure to antibiotics,” Kinch explained carefully. “We’re all just colonized by resistant bacteria now.”
“Three weeks later I was asked to join a nonprofit organization working on new models for drug development, called the Institute for Life Sciences Collaboration,” Kinch said. “The institute was picking the therapeutic areas that would be their focus. “They were considering various exotic diseases, and I said, ‘Antibiotics.’”
Antibiotics are crashing.
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- 'Anti-antibiotic' allows for use of antibiotics without driving resistanceon December 1, 2020 at 5:03 am
An inexpensive, FDA-approved drug -- cholestyramine -- taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at ...
- Farm animals antibiotics data raises post-Brexit trade fearson November 30, 2020 at 9:50 pm
Use of antibiotics on farms in US and Canada about five times the UK level, says report ...
- Small molecules control bacterial resistance to antibioticson November 30, 2020 at 7:30 am
Antibiotics have revolutionized medicine by providing effective treatments for infectious diseases such as cholera. But the pathogens that cause disease are increasingly developing resistance to the ...
- Excessive use of antibiotics during COVID-19 pandemic could intensify drug resistanceon November 30, 2020 at 6:02 am
A new study published in the journal Science of The Total Environment in November 2020 discusses this potentially serious issue along with its wider consequences.
- Antibiotics Market : Industry Analysis, Size, Share, Growth, Trends and Forecast 2021 - 2030on November 24, 2020 at 9:56 pm
Global antibiotics market will reach $63.99 billion by 2030, growing by 3.5% annually over 2020-2030 driven by ...
- Europe Oral Antibiotics Market Future Scope, Opportunities with Strategic Growth and Top Playerson November 24, 2020 at 9:42 pm
Europe oral antibiotics market accounted for $4,612.4 million in 2019 and will grow by 3.8% annually over 2020-2030 ...
- Global Antibiotics Market to Grow by $4.44 Billion During 2020-2024 | Rising Prevalence of Infectious Diseases to Boost Growth | Technavioon November 24, 2020 at 9:30 pm
The global antibiotics market size is expected to grow by USD 4.44 billion during 2020-2024, progressing at a CAGR of over 3% during the forecast period. According to the latest research report by ...
- Global Antibiotics Market to Grow by $4.44 Billion During 2020-2024 | Rising Prevalence of Infectious Diseases to Boost Growthon November 24, 2020 at 5:35 pm
Rising Prevalence of Infectious Diseases to Boost Growth \| Technavio Business Wire LONDON -- November 24, 202 ...
- Researchers present insights in the search for new antibioticson November 19, 2020 at 1:24 pm
A collaborative research team from the University of Oklahoma, the Memorial Sloan Kettering Cancer Center and Merck & Co. published an opinion article in the journal, Nature Chemical Biology, that ...
- Solving a mystery: How the TB bacterium develops rapid resistance to antibioticson November 19, 2020 at 12:35 pm
These slow growing bacteria have long puzzled TB researchers with their fairly rapid resistance to antibiotics. Researchers may have been barking up the wrong tree in exploring genetics, because the ...
via Bing News